Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bill

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 26, 2015
The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcomaKate Lynn J Bill, Jeannine Garnett, Xiaoyan Ma, et al.
Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery|December 1, 1994
A new device for securing meshed split-thickness skin graftsH N Himel, G T Rodeheaver, A Luterman, et al.
Archives of Neurology|June 1, 1996
Motor changes in presymptomatic Huntington disease gene carriersE Siemers, T Foroud, D J Bill, et al.
Plos One|July 23, 2015
HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)Gonzalo Lopez, Kate Lynn J Bill, Hemant Kumar Bid, et al.
Prehospital Emergency Care|January 28, 2014
Comparison of droperidol and haloperidol for use by paramedics: assessment of safety and effectivenessMarlow Macht, Ashley C Mull, Kevin E McVaney, et al.
Nucleic Acids Research|December 8, 2011
Minimotif Miner 3.0: database expansion and significantly improved reduction of false-positive predictions from consensus sequencesTian Mi, Jerlin Camilus Merlin, Sandeep Deverasetty, et al.
Cancer Cell International|July 10, 2018
miR-133a function in the pathogenesis of dedifferentiated liposarcomaPeter Y Yu, Gonzalo Lopez, Danielle Braggio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2015
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J Bill, Jeannine Garnett, Isabelle Meaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Correction: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J Bill, Jeannine Garnett, Isabelle Meaux, et al.
The Oncologist|April 26, 2019
Degree of <i>MDM2</i> Amplification Affects Clinical Outcomes in Dedifferentiated LiposarcomaKate Lynn J Bill, Nathan D Seligson, John L Hays, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 26, 2015
The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcomaKate Lynn J Bill, Jeannine Garnett, Xiaoyan Ma, et al.
Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery|December 1, 1994
A new device for securing meshed split-thickness skin graftsH N Himel, G T Rodeheaver, A Luterman, et al.
Archives of Neurology|June 1, 1996
Motor changes in presymptomatic Huntington disease gene carriersE Siemers, T Foroud, D J Bill, et al.
Plos One|July 23, 2015
HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)Gonzalo Lopez, Kate Lynn J Bill, Hemant Kumar Bid, et al.
Prehospital Emergency Care|January 28, 2014
Comparison of droperidol and haloperidol for use by paramedics: assessment of safety and effectivenessMarlow Macht, Ashley C Mull, Kevin E McVaney, et al.
Nucleic Acids Research|December 8, 2011
Minimotif Miner 3.0: database expansion and significantly improved reduction of false-positive predictions from consensus sequencesTian Mi, Jerlin Camilus Merlin, Sandeep Deverasetty, et al.
Cancer Cell International|July 10, 2018
miR-133a function in the pathogenesis of dedifferentiated liposarcomaPeter Y Yu, Gonzalo Lopez, Danielle Braggio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2015
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J Bill, Jeannine Garnett, Isabelle Meaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Correction: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J Bill, Jeannine Garnett, Isabelle Meaux, et al.
The Oncologist|April 26, 2019
Degree of <i>MDM2</i> Amplification Affects Clinical Outcomes in Dedifferentiated LiposarcomaKate Lynn J Bill, Nathan D Seligson, John L Hays, et al.
Pageof 11